Lantheus Holdings Inc. - notizie pubblicate 285 - letture 5.101
LANTHEUS HOLDINGS INC.
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Lantheus to present piflufolastat f 18 data at the 2023 american society of clinical oncology (asco) genitourinary cancers symposium february 8, 2023 bedford, mass., feb. 08, 2023 ...
LANTHEUS HOLDINGS INC.
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer's Disease - Form 8-K
Lantheus announces acquisition of cerveau technologies, inc., expanding imaging pipeline into alzheimer's disease mk-6240 is an f18-labeled pet imaging agent that targets tau tangl ...
LANTHEUS HOLDINGS INC.
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease
Lantheus announces acquisition of cerveau technologies, inc., expanding imaging pipeline into alzheimer's disease february 6, 2023 mk-6240 is an f 18-labeled pet imaging agent that ...
LANTHEUS HOLDINGS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
LANTHEUS HOLDINGS INC.
Regulation FD Presentation - Form 8-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...
LANTHEUS HOLDINGS INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
LANTHEUS HOLDINGS INC.
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
Lantheus to present at the j.p. morgan 2023 healthcare conference january 4, 2023 north billerica, mass., jan. 04, 2023 (globe newswire) --lantheus holdings, inc.("the company ...
LANTHEUS HOLDINGS INC.
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
Lantheus announces closing of strategic collaboration and exclusive license agreements for the commercialization of pnt2002 & pnt2003 with point biopharma december 20, 2022 nor ...
LANTHEUS HOLDINGS INC.
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma - Form 8-K
Lantheus announces closing of strategic collaboration and exclusive license agreements for the commercialization of pnt2002 & pnt2003 with point biopharma north billerica, ma, ...
LANTHEUS HOLDINGS INC.
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
Lantheus holdings, inc. announces pricing of offering of $500 million convertible senior notes due 2027 december 6, 2022 north billerica, mass., dec. 06, 2022 (globe newswire) -- l ...
LANTHEUS HOLDINGS INC.
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027 - Form 8-K
Lantheus holdings, inc. announces pricing of offering of $500 million convertible senior notes due 2027 north billerica, mass., december 6, 2022 - lantheus holdings, inc. (the &quo ...
LANTHEUS HOLDINGS INC.
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027 - Form 8-K
Lantheus holdings, inc. announces proposed offering of $500 million convertible senior notes due 2027 north billerica, mass., december 5, 2022 - lantheus holdings, inc. (the " ...
LANTHEUS HOLDINGS INC.
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027
Lantheus holdings, inc. announces proposed offering of $500 million convertible senior notes due 2027 december 5, 2022 north billerica, mass., dec. 05, 2022 (globe newswire) -- lan ...
LANTHEUS HOLDINGS INC.
Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
Lantheus announces appointment of amanda morgan as senior vice president, commercial november 29, 2022 north billerica, mass., nov. 29, 2022 (globe newswire) -- lantheus holdings, ...
LANTHEUS HOLDINGS INC.
Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer lantheus holdings in ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti